Plenoinc
1 known investors
Pleno develops an instrument platform for genomic testing that enables AI-driven precision medicine through faster, lower-cost multiomics analysis. The platform targets the clinical genomics market, particularly oncology and other applications where genomic testing can improve patient outcomes.
AI & Machine LearningBiotechMedical Devices